Literature DB >> 12408358

Analysis of IL-2, IFN-gamma and TNF-alpha production, alpha5 beta1 integrins and actin filaments distribution in peritoneal mouse macrophages treated with homeopathic medicament.

M Da Rocha Piemonte1, D De Freitas Buchi.   

Abstract

The newer forms of immune modulatory therapy are aimed at specific cells or cytokines that contribute to the immune response. These forms of immunotherapy have been referred to as 'biological response modifiers'. Our lab was interested in investigating if a homeopathic medicament 'Metodo Canova' (MC), sold in homeopathic drugstores, does enhance immunological system responses acting through macrophages pathway. Mice peritoneal macrophages were cultivated with or without homeopathic medicament for 24 h for alpha5, beta1 and actin filaments distribution analyses through immunolabelling for confocal microscopy. To detect the IL-2, IFN-gamma and TNF-alpha production these cells were cultivated for 48 h with or without medicament, followed by analyses of these cytokines in supernatant culture with ELISA kits. It was observed differences in morphology and molecular distribution (alpha5 and beta1 integrins, actin filaments and Fc receptors) between the groups control and treated with MC. In control group macrophages had the morphology of resident cells and in MC treated group macrophages were more spread, had many cellular projections and a substantial increase in cytoplasmic volume. In addition, macrophages culture with two doses of MC showed that TNF-alpha production decreased when compared with control group.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408358

Source DB:  PubMed          Journal:  J Submicrosc Cytol Pathol        ISSN: 1122-9497


  6 in total

Review 1.  Role of cellular events in the pathophysiology of sepsis.

Authors:  Chandra Bhan; Pankaj Dipankar; Papiya Chakraborty; Pranita P Sarangi
Journal:  Inflamm Res       Date:  2016-07-08       Impact factor: 4.575

2.  In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model.

Authors:  Fernando S F Guimarães; Lucas F Andrade; Sharon T Martins; Ana P R Abud; Reginaldo V Sene; Carla Wanderer; Inés Tiscornia; Mariela Bollati-Fogolín; Dorly F Buchi; Edvaldo S Trindade
Journal:  BMC Cancer       Date:  2010-03-25       Impact factor: 4.430

3.  Experimental gastric carcinogenesis in Cebus apella nonhuman primates.

Authors:  Joana de Fátima Ferreira Borges da Costa; Mariana Ferreira Leal; Tanielly Cristina Raiol Silva; Edilson Ferreira Andrade Junior; Alexandre Pingarilho Rezende; José Augusto Pereira Carneiro Muniz; Antonio Carlos Cunha Lacreta Junior; Paulo Pimentel Assumpção; Danielle Queiroz Calcagno; Samia Demachki; Silvia Helena Barem Rabenhorst; Marília de Arruda Cardoso Smith; Rommel Rodriguez Burbano
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

4.  Stimulation of lymphocyte anti-melanoma activity by co-cultured macrophages activated by complex homeopathic medication.

Authors:  Fernando S F Guimarães; Ana P R Abud; Simone M Oliveira; Carolina C Oliveira; Beatriz César; Lucas F Andrade; Lucélia Donatti; Juarez Gabardo; Edvaldo S Trindade; Dorly F Buchi
Journal:  BMC Cancer       Date:  2009-08-22       Impact factor: 4.430

5.  Eugenia uniflora L. Essential Oil as a Potential Anti-Leishmania Agent: Effects on Leishmania amazonensis and Possible Mechanisms of Action.

Authors:  Klinger Antonio da Franca Rodrigues; Layane Valéria Amorim; Jamylla Mirck Guerra de Oliveira; Clarice Noleto Dias; Denise Fernandes Coutinho Moraes; Eloisa Helena de Aguiar Andrade; Jose Guilherme Soares Maia; Sabrina Maria Portela Carneiro; Fernando Aécio de Amorim Carvalho
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-20       Impact factor: 2.629

6.  Treatment with at homeopathic complex medication modulates mononuclear bone marrow cell differentiation.

Authors:  Beatriz Cesar; Ana Paula R Abud; Carolina C de Oliveira; Francolino Cardoso; Raffaello Popa Di Bernardi; Fernando S F Guimarães; Juarez Gabardo; Dorly de Freitas Buchi
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-17       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.